Search research articles
Contact Us
Filters
Showing results (171-180 of 212) with videos related to
Page
of 22
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)
Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
AIDS (London, England)
|
May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trial
Christopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 5, 2024
Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIV
Maheen Z Abidi, Triin Umbleja, Edgar T Overton, et al.
AIDS (London, England)
|
June 18, 2025
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV
Kristine M Erlandson, Ashley McKhann, Douglas W Kitch, et al.
The Lancet. HIV
|
April 3, 2025
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial
Marissa R Diggs, Triin Umbleja, Sara McCallum, et al.
Open Forum Infectious Diseases
|
June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIV
Grace L Kulik, Triin Umbleja, Todd T Brown, et al.
Open Forum Infectious Diseases
|
March 31, 2023
Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus
Samuel R Schnittman, Douglas W Kitch, Talia H Swartz, et al.
JAMA Cardiology
|
December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial
Márton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
Open Forum Infectious Diseases
|
October 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV
Markella V Zanni, Triin Umbleja, Carl J Fichtenbaum, et al.
JACC. Advances
|
August 21, 2025
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
Kristine M Erlandson, Ariela R Orkaby, Triin Umbleja, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 212) with videos related to
Sort By:
Page
of 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)
Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
AIDS (London, England)
|
May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trial
Christopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 5, 2024
Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIV
Maheen Z Abidi, Triin Umbleja, Edgar T Overton, et al.
AIDS (London, England)
|
June 18, 2025
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV
Kristine M Erlandson, Ashley McKhann, Douglas W Kitch, et al.
The Lancet. HIV
|
April 3, 2025
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial
Marissa R Diggs, Triin Umbleja, Sara McCallum, et al.
Open Forum Infectious Diseases
|
June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIV
Grace L Kulik, Triin Umbleja, Todd T Brown, et al.
Open Forum Infectious Diseases
|
March 31, 2023
Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus
Samuel R Schnittman, Douglas W Kitch, Talia H Swartz, et al.
JAMA Cardiology
|
December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial
Márton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
Open Forum Infectious Diseases
|
October 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV
Markella V Zanni, Triin Umbleja, Carl J Fichtenbaum, et al.
JACC. Advances
|
August 21, 2025
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
Kristine M Erlandson, Ariela R Orkaby, Triin Umbleja, et al.
Page
of 22